Chi Sheng Pharma & Biotech , Ltd Total Current Liabilities

The latest total current liabilities for 4111.TWO is $540M as of June 2026. That compares with $460M in the prior-year period — up 18.7% year over year. Investors often review this figure alongside Chi Sheng Pharma & Biotech , Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4111.TWO's total current liabilities moved from $460M to $540M — a 18.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chi Sheng Pharma & Biotech , Ltd's operating scale or balance-sheet position.

A total current liabilities figure of $540M for 4111.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4111.TWO's total current liabilities ($540M), review year-over-year change from $460M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.